CBMJ
Get informed when a big investor buys or sells
+ FollowOvervalued by 232.7% based on the discounted cash flow analysis.
| Market cap | $17,341.00 |
|---|---|
| Enterprise Value | $448,975.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.03 |
| Beta | 1.38 |
| Outstanding Shares | 113,026,225 |
| P/E Ratio | -1.6 |
|---|---|
| PEG | 1.47 |
| Price to Sales | - |
| Price to Book Ratio | -0.01 |
| Enterprise Value to Revenue | 4.13 |
| Enterprise Value to EBIT | -1.05 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.99 |
| Debt to Equity | 1.34 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data